Psychiatric Medication in Pregnancy and Lactation

February, 2009 | Vol: 7 Issue: 2

In this issue

Learning Objective

Learning Objectives, Feb. 2009

This CME/CE activity is intended for psychiatrists, psychiatric nurses, psychologists and other health care professionals with an interest in the diagnosis and treatment of psychiatric disorders.


Psychotropics and Pregnancy: An Update

On May 28, 2008, The Food and Drug Administration announced a major revision in the labeling of the pregnancy and breast-feeding risk of drugs. The current labeling system was devised in 1979 and has been criticized over the years for being confusing and for failing to incorporate the most recent data. In the new system, package inserts will carry a short monograph on the pregnancy and lactation risks of each drug.

Breast Feeding and Psychiatric Medications: An Overview

Any discussion of psychiatric medications and breastfeeding must begin with the benefits of breastfeeding, which are substantial. While all psychotropic medications enter the breast milk, medication exposure for a nursing infant is much less than the exposure to a fetus during pregnancy. As is the case for pregnant women, it is important to work with breastfeeding women to find the lowest effective dose.

Editorial Information

Research Update

Expert QA